{"version":"1.0","type":"link","title":"Matching-Adjusted Indirect Treatment Comparison of Tarlatamab Versus Comparator Therapies in England in Patients with Extensive-Stage Small Cell Lung Cancer Who Have Received Two or More Prior Lines of Therapy.","author_name":"Takundwa R 외","author_url":"https://prs-insight.online/author/Takundwa%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/101173","thumbnail_width":1200,"thumbnail_height":630}